152517-44-7

Basic information

• Product Name: 2-Butanol, 4-[1-[4-[[3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-2-Methyl-, [1S-[1α(R*),3aβ,4E(1Z,3R*,5S*),7aα]]- (9CI)
• Synonyms: 2-Butanol, 4-[1-[4-[[3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-2-Methyl-, [1S-[1α(R*),3aβ,4E(1Z,3R*,5S*),7aα]]- (9CI);4-((S)-1-((1S,3aS,7aS,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)ethoxy)-2-methylbutan-2-ol;4-((S)-1-((1S,3aS,7aS,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)ethoxy)-2-methylb...
• CAS NO: 152517-44-7
• Molecular Formula: C₃₈H₇₀O₄Si₂
• Molecular Weight: 647.131
• Mol File: 152517-44-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 632.6±55.0 °C(Predicted)
• Appearance: /
• Density: 0.97±0.1 g/cm3(Predicted)
• PKA: 15.01±0.29(Predicted)
• CAS DataBase Reference: 2-Butanol, 4-[1-[4-[[3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-2-Methyl-, [1S-[1α(R*),3aβ,4E(1Z,3R*,5S*),7aα]]- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Butanol, 4-[1-[4-[[3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-2-Methyl-, [1S-[1α(R*),3aβ,4E(1Z,3R*,5S*),7aα]]- (9CI)(152517-44-7)
• EPA Substance Registry System: 2-Butanol, 4-[1-[4-[[3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-2-Methyl-, [1S-[1α(R*),3aβ,4E(1Z,3R*,5S*),7aα]]- (9CI)(152517-44-7)

Safety Data

• Hazardous Substances Data: 152517-44-7(Hazardous Substances Data)

Upstream product

• 1397264-47-9 1(S),3(R)-bis(tertbutyldimethylsililoxy)-22-oxa-25-hydroxy-9,10-secocholesta-5(E),7(E),10⁽¹⁹⁾-triene 
• 1397694-63-1 1(S),3(R)-bis(tertbutyldimethylsililoxy)-20(S)-hydroxy-9,10-secopregna-5,7(E),10⁽¹⁹⁾-triene 
• 1397694-62-0 1(S),3(R)-bis(tertbutyldimethylsililoxy)-9,10-secopregna-5,7(E),10⁽¹⁹⁾,17-tetraene 
• 1397694-61-9 1(S),3(R)-bis(tertbutyldimethylsililoxy)-20(R)-hydroxy-9,10-secopregna-5,7(E),10⁽¹⁹⁾-triene 
• 131830-01-8 1(S),3(R)-bis(tertbutyldimethylsililoxy)-20(R)-hydroxy-9,10-secopregna-5,7(E),10⁽¹⁹⁾-triene 
• 131711-72-3 1(S),3(R)-bis(tertbutyldimethylsililoxy)-20(S)-hydroxy-9,10-secopregna-5,7(E),10⁽¹⁹⁾-triene 
• 131711-71-2 1(S),3(R)-bis(tertbutyldimethylsililoxy)-20-one-9,10-secopregna-5,7(E),10⁽¹⁹⁾-triene 
• 112828-13-4 (5E,7E)-(1S,3R,20S)-1,3-bis<<(1,1-dimethylethyl)dimethylsilyl>oxy>-20-methyl-9,10-secopregna-5,7,10(19)-trien-21-al 

Relevant articles and documents

POLYMORPHS OF MAXACALCITOL AND PROCESS FOR THE PREPARATION OF MAXACALCITOL

The present invention relates to Maxacalcitol polymorphs and Maxacalcitol having low residual solvent content as well as processes for their preparation. The present invention also relates to pharmaceutical compositions containing Maxacalcitol polymorphs or Maxacalcitol having low residual solvent content and treatment methods using the pharmaceutical compositions.